Why Is Steris (STE) Up 0.4% Since Last Earnings Report?

Steris (STE) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Dec 5, 2025

Should You Hold STERIS Stock in Your Portfolio for Now?

STE posts solid AST and Healthcare growth, but currency swings and macro pressures pose rising challenges.

Zacks Investment Research • Dec 4, 2025

Steris (STE) Upgraded to Buy: Here's Why

Steris (STE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Nov 20, 2025

Interpreting Steris (STE) International Revenue Trends

Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Zacks Investment Research • Nov 10, 2025

STERIS plc (STE) Q2 2026 Earnings Call Transcript

STERIS plc ( STE ) Q2 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Julie Winter - Vice President of Investor Relations & Corporate Communications Karen Burton - Senior VP, CFO & Chief Accounting Officer Daniel Carestio - President, CEO & Director Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Patrick Wood - Morgan Stanley, Research Division Jason Bednar - Piper Sandler & Co., Research Division Michael Matson - Needham & Company, LLC, Research Division Michael Polark - Wolfe Research, LLC Presentation Operator Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today.

Seeking Alpha • Nov 6, 2025

STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up

STERIS posts strong Q2 results with earnings and revenue beats, margin expansion, and a raised 2026 EPS outlook.

Zacks Investment Research • Nov 6, 2025

STERIS Announces Financial Results for Fiscal 2026 Second Quarter

Total revenue from continuing operations increased 10%; constant currency organic revenue grew 9% As reported EPS from continuing operations increased to $1.94; adjusted EPS increased to $2.47 Fiscal 2026 constant currency organic revenue, EPS and free cash flow outlook increased DUBLIN, IRELAND , Nov. 05, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 second quarter ended September 30, 2025. Total revenue from continuing operations for the second quarter of fiscal 2026 increased 10% to $1.5 billion compared with $1.3 billion in the second quarter of fiscal 2025.

GlobeNewsWire • Nov 5, 2025

Steris (STE) Surpasses Q2 Earnings and Revenue Estimates

Steris (STE) came out with quarterly earnings of $2.47 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.14 per share a year ago.

Zacks Investment Research • Nov 5, 2025

Here's What Key Metrics Tell Us About Steris (STE) Q2 Earnings

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Nov 6, 2025

Seeking Clues to Steris (STE) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Steris (STE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Zacks Investment Research • Nov 4, 2025